Nephrology

Chase Medical Research has conducts clinical trials for Nephrology in the areas of Chronic Kidney Disease, Diabetic Kidney Disease, and Chronic Kidney Disease with Anemia.

We participated in a clinical trial testing Kerendia (Finerenone) which was recently approved by the FDA. This medication improves kidney and heart outcomes in adults with chronic kidney disease associated with type 2 diabetes.

References:

Center for Drug Evaluation and Research. “FDA Approves Drug for Chronic Kidney Disease.” U.S. Food and Drug Administration, FDA